Technical Analysis for PBIO - Pressure Biosciences
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Up |
Historical PBIO trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Support | Bullish | 0.00% | |
20 DMA Support | Bullish | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Crossed Above 200 DMA | Bullish | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
200 DMA Resistance | Bearish | 7.50% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 7.50% | |
Calm After Storm | Range Contraction | 7.50% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Get a Trading Assistant
Pressure Biosciences Description
Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Nature Biology Drug Discovery Cell Biology Application Development Biomarkers Biomarker Otc Markets Group Histology Cycling Technology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.49 |
52 Week Low | 1.3 |
Average Volume | 15,467 |
200-Day Moving Average | 2.0133 |
50-Day Moving Average | 2.2906 |
20-Day Moving Average | 2.1015 |
10-Day Moving Average | 2.0440 |
Average True Range | 0.2533 |
ADX | 28.23 |
+DI | 16.6648 |
-DI | 25.1707 |
Chandelier Exit (Long, 3 ATRs ) | 1.8401 |
Chandelier Exit (Short, 3 ATRs ) | 2.3699 |
Upper Bollinger Band | 2.3510 |
Lower Bollinger Band | 1.8520 |
Percent B (%b) | 0.6 |
BandWidth | 23.7449 |
MACD Line | -0.0579 |
MACD Signal Line | -0.0728 |
MACD Histogram | 0.0148 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.4500 | ||||
Resistance 3 (R3) | 2.4167 | 2.2833 | 2.4000 | ||
Resistance 2 (R2) | 2.2833 | 2.2069 | 2.3000 | 2.3833 | |
Resistance 1 (R1) | 2.2167 | 2.1597 | 2.2500 | 2.2500 | 2.3667 |
Pivot Point | 2.0833 | 2.0833 | 2.1000 | 2.1000 | 2.0833 |
Support 1 (S1) | 2.0167 | 2.0069 | 2.0500 | 2.0500 | 1.9333 |
Support 2 (S2) | 1.8833 | 1.9597 | 1.9000 | 1.9167 | |
Support 3 (S3) | 1.8167 | 1.8833 | 1.9000 | ||
Support 4 (S4) | 1.8500 |